IPSC Projected Dividend Yield
Century Therapeutics Inc ( NASDAQ : IPSC )Century Therapeutics, Inc. is a biotechnology company. Co. is focused on developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. Co. has created allogeneic cell therapy platform that includes induced pluripotent stem cells (iPSCs), differentiation know-how to generate immune effector cells from iPSCs, or iPSC- derived cells, clustered regularly interspaced short palindromic repeats, to incorporate multiple transgenes and remove target genes. Co.'s product candidates include CNTY-101, CNTY-102, CNTY-107, CNTY-104, and CNTY-106. 20 YEAR PERFORMANCE RESULTS |
IPSC Dividend History Detail IPSC Dividend News IPSC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |